Ketoconazole hepatotoxicity in a patient treated for environmental illness and systemic candidiasis

Environmental illness, a hypothesized disease caused by exposure to substances such as combustion products, pesticides, food additives, and Candida albicans, is discussed. The case of a patient with environmental illness and systemic candidiasis for six weeks with ketoconazole, liver enzyme concentrations increased. One month after discontinuation of ketoconazole, the liver enzyme concentrations decreased; however, over the next five months, liver enzymes and bilirubin increased. The patient developed encephalopathy and eventually was transferred to a medical center for possible liver transplant. A review of the literature pertaining to ketoconazole hepatotoxicity is also presented.

This article has been cited by other articles:

				R. J. Rodriguez and C. L. Miranda Isoform Specificity of N-Deacetyl Ketoconazole by Human and Rabbit Flavin-Containing Monooxygenases Drug Metab. Dispos., September 1, 2000; 28(9): 1083 - 1086. [Abstract] [Full Text]

				R. J. Rodriguez, P. J. Proteau, B. L. Marquez, C. L. Hetherington, C. J. Buckholz, and K. L. O'Connell Flavin-Containing Monooxygenase-Mediated Metabolism of N-Deacetyl Ketoconazole by Rat Hepatic Microsomes Drug Metab. Dispos., August 1, 1999; 27(8): 880 - 886. [Abstract] [Full Text]